HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Repiscak Selected Research
Peter Repiscak Research Topics
Disease
7
Prostatic Neoplasms (Prostate Cancer)
04/2022 - 01/2018
5
Neoplasms (Cancer)
04/2022 - 01/2016
1
Neoplasm Metastasis (Metastasis)
04/2022
1
Polyploidy
12/2020
1
Disease Resistance
11/2020
1
Carcinogenesis
01/2020
Drug/Important Bio-Agent (IBA)
2
Androgens
IBA
01/2022 - 11/2020
2
Androgen Receptors (Androgen Receptor)
IBA
01/2020 - 01/2020
2
Lipids
IBA
01/2020 - 01/2016
1
Nucleotides
IBA
04/2022
1
N-acetylaspartate (N-acetyl aspartate)
IBA
04/2022
1
RNA (Ribonucleic Acid)
IBA
04/2022
1
Aspartic Acid (Aspartate)
FDA Link
04/2022
1
Glutamic Acid (Glutamate)
FDA Link
04/2022
1
Hormones (Hormone)
IBA
04/2022
1
Sphingolipids
IBA
04/2022
1
Docetaxel (Taxotere)
FDA Link
12/2020
1
Ligands
IBA
01/2020
1
Complement System Proteins (Complement)
IBA
01/2020
1
2,4-dienoyl-CoA reductase
IBA
01/2020
1
Catenins
IBA
01/2020
1
RNA Polymerase III
IBA
01/2020
1
Interleukin-6 (Interleukin 6)
IBA
01/2018
1
Scavenger Receptors (Scavenger Receptor)
IBA
01/2018
1
Biomarkers (Surrogate Marker)
IBA
01/2016
Therapy/Procedure
6
Castration
04/2022 - 01/2018
5
Therapeutics
01/2022 - 01/2016
1
Drug Therapy (Chemotherapy)
12/2020